Landscape Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Landscape Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-90,922	Closed	-$264K	–	821
2017 Q3	$264K	Sell	90,922 -34,330	-27%	-$117K	0.03%	412
2017 Q2	$557K	Sell	125,252 -153,376	-55%	-$632K	0.06%	191
2017 Q1	$1.52M	Buy	278,628 +125,252	+82%	+$726K	0.15%	129
2016 Q4	$934K	Buy	153,376 +130,480	+570%	+$682K	0.13%	167
2016 Q3	$126K	Sell	22,896 -451,892	-95%	-$2.12M	0.02%	409
2016 Q2	$1.8M	Sell	474,788 -525,212	-53%	-$1.78M	0.24%	103
2016 Q1	$2.76M	Buy	1,000,000 +944,254	+1,694%	+$3.42M	0.33%	76
2015 Q4	$316K	Buy	55,746 +4,246	+8%	+$25.9K	0.04%	669
2015 Q3	$273K	Sell	51,500 -4,600	-8%	-$35.6K	0.04%	476
2015 Q2	$466K	Buy	56,100 +3,300	+6%	+$16K	0.08%	381
2015 Q1	$244K	Buy	+52,800	New	+$172K	0.07%	402

Other funds holding SGYP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Landscape Capital Management's SGYP Position: Q4 2017 in Review

Landscape Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2017, closing a stake of 90,922 shares — an estimated $264K sold.

Landscape Capital Management first reported a position in SGYP in Q1 2015 and held it in 11 quarters. The position peaked at $2.76M in Q1 2016. 149 funds tracked by Wall St. Rank hold SGYP as of Q4 2017.

Landscape Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2017 after selling out during the quarter.
Landscape Capital Management sold 90,922 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2017, an estimated $264K.
Landscape Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2015 and held it in 11 quarters.
Landscape Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $2.76M in Q1 2016.
149 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2017.

Based on Landscape Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.